Your shopping cart is currently empty

Hepoxilin A3 (HXA3) is a neutrophil chemoattractant synthesized through the activation of the PLA2-12-LOX pathway. It directs neutrophils to migrate across epithelial barriers to sites of infection, such as the alveolar space. In mouse models, levels of Hepoxilin A3 rise in tandem with neutrophil infiltration. It is used in research on inflammatory diseases like pneumonia and cystic fibrosis.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Hepoxilin A3 (HXA3) is a neutrophil chemoattractant synthesized through the activation of the PLA2-12-LOX pathway. It directs neutrophils to migrate across epithelial barriers to sites of infection, such as the alveolar space. In mouse models, levels of Hepoxilin A3 rise in tandem with neutrophil infiltration. It is used in research on inflammatory diseases like pneumonia and cystic fibrosis. |
| Synonyms | HXA3 |
| Molecular Weight | 336.47 |
| Formula | C20H32O4 |
| Cas No. | 94161-11-2 |
| Smiles | O=C(O)CCCC=CCC(O)C=CC1OC1CC=CCCCCC |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.